Month: February 2021

TULSA, Okla., Feb. 24, 2021 (GLOBE NEWSWIRE) — BOK Financial has received the highest rating – “Outstanding” – for its recent Community Reinvestment Act (CRA) examination from the Office of the Comptroller of the Currency (OCC).Only 23% of US banks assigned a CRA rating last year received an Outstanding rating. The examination covered the bank’s activities from January 1, 2017, through December 31, 2019.In granting the rating, the OCC cited BOK Financial’s excellent distribution of borrower income levels across the loan portfolio; investment in and responsiveness to assessment area needs; and accessibility of branch offices to low and moderate income individuals and families. In particular, the OCC singled out BOK Financial’s positive impact on the Kansas City metropolitan area as well as Arizona, Arkansas, Colorado, New Mexico,...

CHARLOTTE, N.C., Feb. 24, 2021 (GLOBE NEWSWIRE) — Extended Stay America, Inc. (NASDAQ:STAY), the largest mid-priced extended-stay hotel brand, announced today the addition of three properties in Oklahoma through franchise conversions. The properties are all owned by Dallas-based Provident Realty Advisors, Inc. and will be operated by Plano, Texas-based Aimbridge Hospitality, the leading, global, third-party hotel management company.The properties include:Extended Stay America Bartlesville – Hwy 75, Bartlesville, OklahomaExtended Stay America McAlester – Hwy 69, McAlester, OklahomaExtended Stay America Lawton – Fort Sill, Lawton, Oklahoma“We are extremely excited to be adding these properties into the ESA brand as we expand our presence into the Oklahoma market,” said Judi Bikulege, Chief Investment Officer, Extended...

PEARL RIVER, N.Y., Feb. 24, 2021 (GLOBE NEWSWIRE) — Sterling National Bank, the wholly-owned operating bank subsidiary of Sterling Bancorp (NYSE: STL) today announced that it is working with Google to offer digital checking and savings accounts through the Google Pay platform. As part of Sterling’s Banking as a Service (BaaS) program, this collaboration with Google Pay marks the latest in a series of strategic partnerships and digital technology investments that will drive growth through access to new segments, contemporary value propositions and a highly efficient delivery model.Customers will be able to leverage a fully digital experience to seamlessly open bank accounts at Sterling via the Google Pay app. Google’s smart platform will help to empower clients’ financial decision-making with personalized insights and a simplified...

NEW YORK and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, and the University of Utah, one of the top research institutions in the United States, today announced a partnership to improve kidney health and reduce the risk of kidney failure for large scale populations in the earliest stages of kidney disease.The partnership intends to implement RenalytixAI’s in vitro diagnostic platform, KidneyIntelX, in combination with a range of advanced clinical management solutions to optimize patient care and drive towards improved outcomes system-wide at University of Utah Health, which serves millions of patients in six states. KidneyIntelX is designed for the identification of adults with early-stage chronic kidney disease and...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Nanotec” or “AREV”), is pleased to announce the addition of Kevin J. Phelps to its Board of Directors. Mr. Phelps has a long history in the biotechnology and drug discovery industries, currently serving as the CEO of Immune Therapeutics, Inc. (IMUN), a publicly-traded company focused on mid-stage immune-based therapies, and as Chairman of OyaGen, Inc., a privately-held early-stage drug development company dedicated to developing new therapeutics to address a variety of viral pathogens and oncological indications.AREV Nanotec CEO Mike Withrow stated, “I am excited to welcome Kevin Phelps to our Board of Directors. Our leadership is quickly maturing into one reflective of the expertise needed to advance new therapies...

$170,000 grants will fill critical gap for 3,000 food insecure families in Greater Boston via Food For Free’s new grocery box programCAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) — Life Science Cares Boston and the Biogen Foundation have teamed up as inaugural sponsors of Food For Free’s new Just Eats Grocery Box program, a $170,000 effort to reduce food insecurity for 3,000 area families, starting this month. To launch Just Eats, Life Science Cares, the life science industry platform for giving back, has committed $50,000, and the Biogen Foundation, the philanthropic arm of Cambridge-based neuroscience pioneer Biogen Inc. (Nasdaq: BIIB), has committed $100,000, matching the $50,000 from Life Science Cares and donating an additional $50,000 to combatting food insecurity for children in Greater Boston. Committing an additional...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) (“Gold Standard” or the “Company”) announced today that Jason Attew, President and CEO, will present virtually at the BMO Global Metals & Mining Conference on Wednesday, March 3, 2021 at 3:30 p.m. ET.The presentation will be available on the “Investors” section of the Company’s website.About Gold StandardGold Standard is developing the South Railroad Project, an open pit, heap leach gold project located in Elko County, Nevada. The project is part of a +21,000 hectare land package on the Carlin Trend, and is 100% owned or controlled by Gold Standard. The goal of the Company is to become the low-cost junior producer of choice in Nevada, one of the premier mining jurisdictions in the world.For further information...

VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) — WPD Pharmaceuticals (CSE:WBIO) (8SV1.F) (“WPD” or the “Company”) today announced that it has signed an agreement with CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS”) to obtain Investigational Medicinal Product (“IMP”) for use in the planned clinical trials of Berubicin. WPD will purchase half of the batch previously manufactured for CNS by BSP Pharmaceuticals for the WPD-201 and WPD-201P studies which are planned to begin in the first half of 2021. This IMP will be QP certified by Clinigen Clinical Supplies Management on behalf of WPD under European current Good Manufacture Practice (“cGMP”) requirements.Berubicin is a novel anthracycline candidate for the treatment of a number of serious oncology indications including Glioblastoma Multiforme (GBM). WPD sublicensed...